Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP

Redefining the Viral Reservoirs that Prevent HIV-1 Eradication

(2012) Evelyn Eisele et al.   IMMUNITY

Mechanisms of interaction between protozoan parasites and HIV

(2012) Guadalupe Andreani et al.   Current Opinion in HIV and AIDS

Tuberculosis and HIV Co-Infection

(2012) Andrzej Pawlowski et al.   PLoS Pathogens

The nerve growth factor reduces APOBEC3G synthesis and enhances HIV-1 transcription and replication in human primary macrophages

(2011) T. M. L. Souza et al.   BLOOD

Immunomodulatory Roles of VIP and PACAP in Models of Multiple Sclerosis

(2011) Catalina Abad et al.   CURRENT PHARMACEUTICAL DESIGN

The macrophage in HIV-1 infection: From activation to deactivation?

(2010) Georges Herbein et al.   Retrovirology

RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons

(2009) Alma Sanchez et al.   NEUROPEPTIDES

Donor variation in in vitro HIV-1 susceptibility of monocyte-derived macrophages

(2009) Sebastiaan M. Bol et al.   VIROLOGY

VPAC and PAC receptors: From ligands to function

(2008) Louise Dickson et al.   PHARMACOLOGY & THERAPEUTICS

Vasoactive intestinal peptide inhibits cycloxygenase-2 expression in activated macrophages, microglia, and dendritic cells

(2007) Elena Gonzalez-Rey et al.   BRAIN BEHAVIOR AND IMMUNITY

Neuropeptides activate human mast cell degranulation and chemokine production

(2007) Marianna Kulka et al.   IMMUNOLOGY